Atlas Bio
Atlas Bio is developing an AI foundation model that predicts drug efficacy and safety in virtual patients, potentially reducing years of clinical testing to weeks.
Atlas Bio has raised €11M across 1 funding round from 3 investors, most recently a Seed round in Oct 2026. Based in Basel, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Basel, Switzerlandatlas.bio ↗
Total raised
€11M
€11,210,762
Funding rounds
1
Investors
3
distinct backers
Active since
2026-10
latest 2026-10
Funding by year
EUR raised per year · 2026 YTDAtlas Bio — funding by year — interactive chart.
Data table
| Atlas Bio — funding by year | |
|---|---|
| 2026 | €11M |
Signals
High confidenceRaise-next likelihood15
base rate 44% for Seed
- ▼ Raised very recently
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-10-27 | Seed | €11M | Creandum,First Momentum Ventures,LEA Partners | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData